Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma

  1. Makrakis, D.
  2. Talukder, R.
  3. Lin, G.I.
  4. Diamantopoulos, L.N.
  5. Dawsey, S.
  6. Gupta, S.
  7. Carril-Ajuria, L.
  8. Castellano, D.
  9. de Kouchkovsky, I.
  10. Koshkin, V.S.
  11. Park, J.J.
  12. Alva, A.
  13. Bilen, M.A.
  14. Stewart, T.F.
  15. McKay, R.R.
  16. Tripathi, N.
  17. Agarwal, N.
  18. Vather-Wu, N.
  19. Zakharia, Y.
  20. Morales-Barrera, R.
  21. Devitt, M.E.
  22. Cortellini, A.
  23. Fulgenzi, C.A.M.
  24. Pinato, D.J.
  25. Nelson, A.
  26. Hoimes, C.J.
  27. Gupta, K.
  28. Gartrell, B.A.
  29. Sankin, A.
  30. Tripathi, A.
  31. Zakopoulou, R.
  32. Bamias, A.
  33. Murgic, J.
  34. Fröbe, A.
  35. Rodriguez-Vida, A.
  36. Drakaki, A.
  37. Liu, S.
  38. Lu, E.
  39. Kumar, V.
  40. Lorenzo, G.D.
  41. Joshi, M.
  42. Isaacsson-Velho, P.
  43. Buznego, L.A.
  44. Duran, I.
  45. Moses, M.
  46. Jang, A.
  47. Barata, P.
  48. Sonpavde, G.
  49. Yu, E.Y.
  50. Montgomery, R.B.
  51. Grivas, P.
  52. Khaki, A.R.
  53. Mostra tots els autors/es +
Revista:
Clinical Genitourinary Cancer

ISSN: 1938-0682,  1558-7673

Any de publicació: 2022

Volum: 20

Número: 5

Pàgines: e440-e452

Tipus: Article

DOI: 10.1016/J.CLGC.2022.06.001 GOOGLE SCHOLAR
Font de les dades: Scopus